IPO5 contributes to cetuximab resistance in colorectal cancer by modulating Ras signaling. (linkinghub.elsevier.com)

Authors: Yuan Q … Li X Journal: iScience Published: 2026-10-16 DOI: https://doi.org/10.1016/j.isci.2026.117714